BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26984820)

  • 1. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
    J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
    Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
    Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase have opposite effects on anesthetic sensitivity to propofol.
    Petrenko AB; Yamazaki M; Sakimura K; Kano M; Baba H
    Eur J Pharmacol; 2015 Oct; 765():268-73. PubMed ID: 26318148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
    Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol.
    Petrenko AB; Yamazaki M; Sakimura K; Kano M; Baba H
    Behav Brain Res; 2014 Sep; 271():51-8. PubMed ID: 24906199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
    Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB
    Trexler KR; Eckard ML; Kinsey SG
    Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
    Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
    Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
    J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
    Liu X; Chen Y; Vickstrom CR; Li Y; Viader A; Cravatt BF; Liu QS
    Sci Rep; 2016 Oct; 6():35829. PubMed ID: 27775008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.